Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupentixol and Melitracen in Non-Random Emotional Disorder
NCT04970667Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of flupentixol + melitracen in pseudobulbar affect (PBA), sponsored by Peking University Third Hospital. Started Jan 2018; status: completed.
02
Drugs
flupentixol + melitracen
03
Conditions
pseudobulbar affect (PBA)
Beyond the preview
Go deeper on NCT04970667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04970667.